Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XQEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XQEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XQECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XQECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XQEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XQEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XQENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AH.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AH.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AH.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.289EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.289ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.289ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.289EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.289EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.289ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.289ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.365EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.365EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.365ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.365ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.365EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.365EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.365ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.365ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.252EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.252EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.252ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.252ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.252EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.252EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.252ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.252ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.223EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.223EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.223ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.223ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.223EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.223EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used